Last quarter (Q4 2022), AstraZeneca's total revenue was $11.21B, a decrease of -6.69% from the same quarter last year. In Q4, AstraZeneca's net income was $901.00M. See AstraZeneca’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 44.35B	$ 45.81B	$ 44.35B	$ 37.42B	$ 26.62B	$ 24.38B
Cost of Revenue	$ 12.39B	$ 8.27B	$ 12.39B	$ 12.44B	$ 5.30B	$ 4.92B
Gross Profit	$ 31.96B	$ 37.54B	$ 31.96B	$ 24.98B	$ 21.32B	$ 19.46B
Operating Expense	$ 28.80B	$ 30.69B	$ 27.88B	$ 25.11B	$ 17.40B	$ 18.77B
Operating Income	$ 3.15B	$ 6.85B	$ 4.08B	$ -134.00M	$ 3.92B	$ 690.00M
Net Non Operating Interest Income Expense	$ -1.25B	$ -1.29B	$ -1.25B	$ 1.23B	$ -1.19B	$ -1.24B
Other Income Expense	-	$ -1.37B	$ -225.00M	-	-	-
Pretax Income	$ 2.50B	$ 6.90B	$ 3.04B	$ -265.00M	$ 3.92B	$ 1.55B
Tax Provision	$ -792.00M	$ 938.00M	$ -792.00M	$ -380.00M	$ 772.00M	$ 321.00M
Earnings From Equity Interest Net Of Tax	-	$ -12.00M	$ -5.00M	-	-	-
Net Income Common Stockholders	$ 3.29B	$ 5.96B	$ 3.82B	$ 112.00M	$ 3.20B	$ 1.33B
Basic EPS	$ 1.06	$ 3.84	$ 2.12	$ 0.08	$ 2.44	$ 1.03
Diluted EPS	$ 1.06	$ 3.81	$ 2.11	$ 0.08	$ 2.44	$ 1.03
Basic Average Shares	$ 4.64B	$ 1.55B	$ 1.55B	$ 1.42B	$ 1.31B	$ 1.30B
Diluted Average Shares	$ 4.68B	$ 1.56B	$ 1.56B	$ 1.43B	$ 1.31B	$ 1.30B
Dividend Per Share	$ 1.94	$ 2.90	$ 2.90	$ 2.80	$ 2.81	$ 2.83
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	$ 4.99	-	-	-	$ 4.02	$ 3.50
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	$ 228.00M	$ 208.00M
Total Expenses	$ 41.20B	$ 38.96B	$ 40.27B	$ -37.55B	$ 22.70B	$ 23.69B
Net Income From Continuing And Discontinued Operation	$ 3.29B	$ 5.96B	$ 3.82B	$ 112.00M	$ 3.20B	$ 1.33B
Normalized Income	$ 2.92B	$ 4.88B	$ 2.03B	$ -1.83B	$ 2.19B	$ -441.30M
Interest Expense	$ 1.33B	-	-	-	$ 1.27B	$ 1.40B
EBIT	$ 3.83B	$ 8.49B	$ 4.37B	$ 1.01B	$ 5.19B	$ 2.95B
EBITDA	$ 9.08B	$ 13.88B	$ 9.85B	$ 1.01B	$ 8.34B	$ 6.71B

Currency in USD

AstraZeneca Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing